BPC-157 Oral Capsules contain the Body Protection Compound-157 pentadecapeptide in a gastric-resistant (enteric-coated) capsule format for oral bioavailability research
Relative contraindications may include significant cancer risk factors, bleeding disorders, and concurrent use of anticoagulant medications
Its mechanism of action is primarily mediated by its role as a substrate for NAD + -dependent enzymes such as the sirtuin family (SIRT1-7), poly(ADP-ribose) polymerases (PARPs), and certain ectoenzymes like CD38 and CD157
If our clinician feels there may be an underlying condition it may be recommended that you have a full consultation with one of our doctors
BPC-157 has been studied extensively for tendon healing
For in vitro laboratory stock preparation only, 5-Amino-1MQ may be prepared according to supplier solubility information, lot-specific documentation, and the validated needs of the specific assay